| # | Title | Journal | Year | Citations |
|---|
| 1 | 4th ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 4) | Annals of Oncology | 2018 | 891 |
| 2 | 5th ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 5) | Annals of Oncology | 2020 | 761 |
| 3 | Radiomics: the facts and the challenges of image analysis | European Radiology Experimental | 2018 | 670 |
| 4 | Immunotherapies for hepatocellular carcinoma | Nature Reviews Clinical Oncology | 2022 | 643 |
| 5 | PD-L1 Immunohistochemistry Comparability Study in Real-Life Clinical Samples: Results of Blueprint Phase 2 Project | Journal of Thoracic Oncology | 2018 | 589 |
| 6 | A Practical Approach to the Management of Cancer Patients During the Novel Coronavirus Disease 2019 (COVID-19) Pandemic: An International Collaborative Group | Oncologist | 2020 | 520 |
| 7 | Adaptive mutability of colorectal cancers in response to targeted therapies | Science | 2019 | 290 |
| 8 | Efficacy and safety of pembrolizumab for the treatment of advanced biliary cancer: Results from the KEYNOTE‐158 and KEYNOTE‐028 studies | International Journal of Cancer | 2020 | 288 |
| 9 | Immune signature drives leukemia escape and relapse after hematopoietic cell transplantation | Nature Medicine | 2019 | 253 |
| 10 | EGFR Blockade Reverts Resistance to KRASG12C Inhibition in Colorectal Cancer | Cancer Discovery | 2020 | 245 |
| 11 | Trastuzumab deruxtecan (DS-8201) in patients with HER2-expressing metastatic colorectal cancer (DESTINY-CRC01): a multicentre, open-label, phase 2 trial | Lancet Oncology, The | 2021 | 234 |
| 12 | Circulating tumor DNA reveals genetics, clonal evolution, and residual disease in classical Hodgkin lymphoma | Blood | 2018 | 223 |
| 13 | Pralsetinib for RET fusion-positive non-small-cell lung cancer (ARROW): a multi-cohort, open-label, phase 1/2 study | Lancet Oncology, The | 2021 | 222 |
| 14 | Defining cardiovascular toxicities of cancer therapies: an International Cardio-Oncology Society (IC-OS) consensus statement | European Heart Journal | 2022 | 213 |
| 15 | Combination of Hypoglycemia and Metformin Impairs Tumor Metabolic Plasticity and Growth by Modulating the PP2A-GSK3β-MCL-1 Axis | Cancer Cell | 2019 | 212 |
| 16 | Fasting-mimicking diet and hormone therapy induce breast cancer regression | Nature | 2020 | 198 |
| 17 | The Promises and Challenges of Tumor Mutation Burden as an Immunotherapy Biomarker: A Perspective from the International Association for the Study of Lung Cancer Pathology Committee | Journal of Thoracic Oncology | 2020 | 182 |
| 18 | Targeting the human epidermal growth factor receptor 2 (HER2) oncogene in colorectal cancer | Annals of Oncology | 2018 | 177 |
| 19 | A substrate-specific mTORC1 pathway underlies Birt–Hogg–Dubé syndrome | Nature | 2020 | 177 |
| 20 | ESO–ESMO 4th International Consensus Guidelines for Breast Cancer in Young Women (BCY4) | Annals of Oncology | 2020 | 172 |
| 21 | Anthracycline-induced cardiotoxicity: A multicenter randomised trial comparing two strategies for guiding prevention with enalapril: The International CardioOncology Society-one trial | European Journal of Cancer | 2018 | 163 |
| 22 | Genomic patterns of progression in smoldering multiple myeloma | Nature Communications | 2018 | 163 |
| 23 | Hematopoietic recovery in patients receiving chimeric antigen receptor T-cell therapy for hematologic malignancies | Blood Advances | 2020 | 162 |
| 24 | Phase I/Ib Clinical Trial of Sabatolimab, an Anti–TIM-3 Antibody, Alone and in Combination with Spartalizumab, an Anti–PD-1 Antibody, in Advanced Solid Tumors | Clinical Cancer Research | 2021 | 151 |
| 25 | A practical guide for mutational signature analysis in hematological malignancies | Nature Communications | 2019 | 145 |
| 26 | Deciphering the complex role of thrombospondin-1 in glioblastoma development | Nature Communications | 2019 | 143 |
| 27 | Integrative and comparative genomic analyses identify clinically relevant pulmonary carcinoid groups and unveil the supra-carcinoids | Nature Communications | 2019 | 132 |
| 28 | Unjamming overcomes kinetic and proliferation arrest in terminally differentiated cells and promotes collective motility of carcinoma | Nature Materials | 2019 | 117 |
| 29 | Gut microbiome correlates of response and toxicity following anti-CD19 CAR T cell therapy | Nature Medicine | 2022 | 117 |
| 30 | ILF2 Is a Regulator of RNA Splicing and DNA Damage Response in 1q21-Amplified Multiple Myeloma | Cancer Cell | 2017 | 114 |
| 31 | Next Generation Sequencing (NGS): A Revolutionary Technology in Pharmacogenomics and Personalized Medicine in Cancer | Advances in Experimental Medicine and Biology | 2019 | 114 |
| 32 | The Use of Immunohistochemistry Improves the Diagnosis of Small Cell Lung Cancer and Its Differential Diagnosis. An International Reproducibility Study in a Demanding Set of Cases | Journal of Thoracic Oncology | 2017 | 113 |
| 33 | ESMO Management and treatment adapted recommendations in the COVID-19 era: Breast Cancer | ESMO Open | 2020 | 113 |
| 34 | Management of Cancer and Health After the Clinic Visit: A Call to Action for Self-Management in Cancer Care | Journal of the National Cancer Institute | 2021 | 110 |
| 35 | European Thyroid Association and Cardiovascular and Interventional Radiological Society of Europe 2021 Clinical Practice Guideline for the Use of Minimally Invasive Treatments in Malignant Thyroid Lesions | European Thyroid Journal | 2021 | 110 |
| 36 | Classification of pulmonary neuroendocrine tumors: new insights | Translational Lung Cancer Research | 2017 | 104 |
| 37 | COVID-19 vaccine guidance for patients with cancer participating in oncology clinical trials | Nature Reviews Clinical Oncology | 2021 | 103 |
| 38 | Genomic epidemiology of SARS-CoV-2 reveals multiple lineages and early spread of SARS-CoV-2 infections in Lombardy, Italy | Nature Communications | 2021 | 102 |
| 39 | Timing the initiation of multiple myeloma | Nature Communications | 2020 | 99 |
| 40 | Rab2 promotes autophagic and endocytic lysosomal degradation | Journal of Cell Biology | 2017 | 98 |
| 41 | Antitumor effect of oncolytic virus and paclitaxel encapsulated in extracellular vesicles for lung cancer treatment | Journal of Controlled Release | 2018 | 95 |
| 42 | Research studies on patients' illness experience using the Narrative Medicine approach: a systematic review | BMJ Open | 2016 | 94 |
| 43 | Extracellular vesicles enhance the targeted delivery of immunogenic oncolytic adenovirus and paclitaxel in immunocompetent mice | Journal of Controlled Release | 2019 | 93 |
| 44 | Detection and quantification of SARS-CoV-2 by droplet digital PCR in real-time PCR negative nasopharyngeal swabs from suspected COVID-19 patients | PLoS ONE | 2020 | 92 |
| 45 | Angiogenin and the MMP9‐TIMP2 axis are up‐regulated in proangiogenic, decidual NK‐like cells from patients with colorectal cancer | FASEB Journal | 2018 | 91 |
| 46 | Synergistic effect of fasting-mimicking diet and vitamin C against KRAS mutated cancers | Nature Communications | 2020 | 90 |
| 47 | PINK1-mediated phosphorylation of LETM1 regulates mitochondrial calcium transport and protects neurons against mitochondrial stress | Nature Communications | 2017 | 87 |
| 48 | Biological and prognostic impact of APOBEC-induced mutations in the spectrum of plasma cell dyscrasias and multiple myeloma cell lines | Leukemia | 2018 | 87 |
| 49 | Taming Human Genetic Variability: Transcriptomic Meta-Analysis Guides the Experimental Design and Interpretation of iPSC-Based Disease Modeling | Stem Cell Reports | 2017 | 86 |
| 50 | International prognostic score for asymptomatic early-stage chronic lymphocytic leukemia | Blood | 2020 | 86 |
